Clinical Trials List
2013-10-01 - 2025-04-01
Phase III
Terminated7
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Rita cheng Division of Urology
- 張英勛 Division of Urology
- Yung-Chang Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chuan-Shu Chen Division of Urology
- Jian-Ri Li Division of Urology
- Cheng-Kuang Yang Division of Urology
- Shian-Shiang Wang Division of Urology
- 熊小澐 Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chia-Hsien Chen Division of Urology
- Yeong-Shiau Pu Division of Urology
- Hong-Chiang Chang Division of Urology
- 劉詩彬 Division of Urology
- CHUNG-HSIN CHEN Division of Urology
- Yu-Chieh Tsai Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 江博暉 Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 余家政 Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yi-Hsiu Huang Division of Urology
- Yen-Hwa Chang Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wen-Chi Chen Division of Hematology & Oncology
- Chao-Hsiang Chang Division of Hematology & Oncology
- Chin-Chung Yeh Division of Hematology & Oncology
- Chi-Ping Huang Division of Hematology & Oncology
- Chi-Rei Yang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
36 participants
-
Global
1200 participants
